Thermo Fisher (TMO +2.3%) gains after its Q4 beat estimates on better-than-expected revenue and...

|About: Thermo Fisher Scientific Inc. (TMO)|By:, SA News Editor

Thermo Fisher (TMO +2.3%) gains after its Q4 beat estimates on better-than-expected revenue and improved gross margins. The company's laboratory products and services segment - its largest top-line contributor - saw a 5% revenue increase, while its analytical technologies segment's and specialty diagnostics segments also gained market share.